Solicitation NAICS 541714

Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)

🏢 HEALTH AND HUMAN SERVICES, DEPARTMENT OF 📅 Posted 2025-10-27 ⏳ Due 2025-12-20T04:59:00+00:00
Amendment 3: Team Organization and Capabilities Section The purpose of this amendment is to clarify that the following information, requested in the Teaming Organization and Capabilities section of the Solution Summary, may be included in the Table for Key Personnel: Provide the name, position, and institution of each key team member and describe in 1-2 sentences the skills and experience they bring to the team. If included in the Table for Key Personnel, this information will not count towards the (3) page Solution Summary page limit, however, the Table for Key Personnel must still not exceed (1) page in length. In addition, the Q&A deadline is extended to October 30, 2025 at 11:59PM ET. ---------------------------------------------------------------------------------------------------------------- Amendment 2: Changes to the ISO The purpose of this amendment is to amend the THRIVE ISO. An updated version of the ISO and an updated version of the ISO with tracked changes are included as attachments. Changes to the ISO include: Cost share is now strongly encouraged instead of mandatory. Multi-party teaming arrangements are no longer required. ARPA-H's involvement with regulatory fac...

Notice ID: 3524c5d34a78455da2ff3c7e1d05a21c · View on SAM.gov ↗

Explore more federal-contracting data

Browse opportunities by NAICS code · set-aside category · state & jurisdiction · buying agency

Win more federal contracts

BidChamp gives small businesses AI-powered bid writing, document analysis, and recompete forecasting - for free during your trial.

Sign up free - 14-day trial, no card required